Recent developments in gastrointestinal motility

Scandinavian Journal of Gastroenterology

Volumn 41, Issue SUPPL. 243, 2006, Pages 25-31

  Smout, Andre ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Constipation; Gastro oesophageal reflux; Gastroparesis; Oesophageal motility disorders

Indexed keywords

CONFERENCE PAPER; ESOPHAGUS DISEASE; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HIATUS HERNIA; HUMAN; IMPEDANCE; LOWER ESOPHAGUS SPHINCTER; MANOMETRY; MOTOR DYSFUNCTION; PATHOGENESIS; PERCEPTION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SMALL INTESTINE; STOMACH EMPTYING; CONSTIPATION; PATHOPHYSIOLOGY; REVIEW; STOMACH PARESIS;

CONSTIPATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS; INTESTINE, SMALL;

EID: 33745366156     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600664235     Document Type: Conference Paper

References (46)

1. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities Gut 2001;49:145-51.
2. Leite JP, Johnston BT, Barrett J, Castell DO.Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder Dig Dis Sci 1997;42:1859-65.
3. Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al.Mechanisms of gastroesophageal reflux in patients with reflux esophagitis N Engl J Med 1982;307:1547-52.
4. Lidums I, Checklin H, Mittal RK, Holloway RH.Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease Gut 1998;43:12-6.
5. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH.Control of transient lower esophageal sphincter relaxations and reflux by the GABAb agonist baclofen in normal subjects Gastroenterol 2000;118:7-13.
6. Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH.Control of transient lower oesophageal sphincter relaxations and reflux by the GABAb agonist baclofen in patients with gastro-oesophageal reflux disease Gut 2002;50:19-24.
7. van Herwaarden MA, Samsom M, Rydholm H, Smout AJPM.The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease Aliment Pharmacol Ther 2002;16:1655-62.
8. Vela MF, Tutuian R, Katz PO, Castell DO.Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH Aliment Pharmacol Ther 2003;17:243-51.
9. Kahrilas PJ, Lin S, Chen J, Manka M.The effect of hiatus hernia on gastro-oesophageal junction pressure Gut 1999;44:476-82.
10. van Herwaarden MA, Samsom M, Smout AJPM.Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations Gastroenterology 2000;119:1439-46.
11. Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ.Ambulatory esophageal pH monitoring using a wireless system Am J Gastroenterol 2003;98:740-9.
12. Nguyen HN, Silny J, Matern S.Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: current results and further implications Am J Gastroenterol 1999;94:306-17.
13. Sifrim D, Holloway R, Silny J, Xin Z, Tack J, Lerut A, et al.Acid, nonacid and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings Gastroenterology 2001;120:1588-98.
14. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO.Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole Gastroenterology 2001;120:1599-606.
15. Vela MF, Tutuian RI, Sifrim D, Shay SS, Zhang X, Castell DO.Comparison of pH-metry versus combined multichannel intraluminal impedance and pH (MII-pH) for symptom association studies in symptomatic acid suppressed GERD patients Gastroenterology 2003;124:A542.
16. Bredenoord AJ, Weusten BLAM, Sifrim D, Timmer R, Smout AJPM. Aerophagia, gastric and supragastric belching. A study using intraluminal electrical impedance monitoring. GutX 2004. In press.
17. Viramontes BE, Kim DY, Cammilleri M, Lee JS, Stephens D, Burton DD, et al.Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying Neurogastroenterol Motil 2001;13:567-74.
18. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, et al.Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial Aliment Pharmacol Ther 2000;14:1653-61.
19. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, et al.Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomized, double blind, placebo controlled trial GutX 2001;49:395-401.
20. Lin Z, Forster J, Sarosiek I, McCallum RW.Treatment of gastroparesis with electrical stimulation Dig Dis Sci 2003;48:837-48.
21. McCallum RW, Chen JD, Lin Z, Schirmer BD, Williams RD, Ross RA.Gastric pacing improves emptying and symptoms in patients with gastroparesis Gastroenterology 1998;114:456-61.
22. Lin Z, Forster J, Sarosiek I, McCallum RW.Effects of high-frequency gastric electrical stimulation of gastric myoelectric activity in gastroparetic patients Neurogastroenterol Mot 2004;16:205-12.
23. Abell TL, Van Cutsem E, Abrahamsson H, Huizinga JD, Konturek JW, Galmiche JP, et al.Gastric electrical stimulation in intractable symptomatic gastroparesis Digestion 2002;66:204-12.
24. Wingate D, Hongo M, Kellow J, Lindberg G, Smout A.Disorders of gastrointestinal motility: towards a new classification J Gastroenterol Hepatol 2002;17:S1-14.
25. Jebbink HJ, Van Berge Henegouwen GP, Akkermans LM, Smout AJ. Small intestinal motor abnormalities in patients with functional dyspepsia demonstrated by ambulatory manometry GutX 1996;38:694-700.
26. Redmond JM, Smith GW, Barofsky I, Ratych RE, Goldsborough DC, Schuster MM.Physiological tests to predict long-term outcome of total abdominal colectomy for intractable constipation Am J Gastroenterol 1995;90:748-53.
27. Glia A, Akerlund JE, Lindberg G.Outcome of colectomy for slow-transit constipation in relation to presence of small-bowel dysmotility Dis Colon Rectum 2004;47:96-102.
28. De Schryver AMP, Andriesse GI, Samsom M, Smout AJPM, Gooszen HG, Akkermans LMA.The effects of the specific 5HT4 receptor agonist, prucalopride, on colonic motility in healthy volunteers Aliment Pharmacol Ther 2002;16:603-12.
29. Bassotti G, Gaburri M, Imbimbo BP, Rossi L, Farroni F, Pelli MA, et al.Colonic mass movements in idiopathic chronic constipation Gut 1988;29:1173-9.
30. Rao SSC, Sadeghi P, Batterson K, Beaty J.Altered periodic rectal motor activity: a mechanism for slow transit constipation Neurogastroenterol Mot 2001;13:591-8.
31. Hagger R, Kumar D, Benson M, Grundy A. Colonic motor activity in slow-transit idiopathic constipation as identified by 24-h pancolonic ambulatory manometry Neurogastroenterol Mot 2003;15:515-22.
32. Preston DM, Lennard-Jones JE.Pelvic motility and response to intraluminal bisacodyl in slow-transit constipation Dig Dis Sci 1985;30:289-94.
33. Kamm MA, van der Sijp JR, Lennard-Jones JE.Observations on the characteristics of stimulated defaecation in severe idiopathic constipation Int J Colorect Dis 1992;7:197-201.
34. Bassotti G, Chiarioni G, Germani U, Battaglia E, Vantini I, Morelli A.Endoluminal instillation of bisacodyl in patients with severe (slow transit type) constipation is useful to test residual colonic propulsive activity Digestion 1999;60:69-73.
35. De Schryver AMP, Samsom M, Smout AJPM.Effects of a meal and bisacodyl on colonic motility in healthy volunteers and patients with slow-transit constipation Dig Dis Sci 2003;48:1206-12.
36. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN.Functional gastroduodenal disorders Gut 1999;45 Suppl:II37-42.
37. Guelrud M, Mendoza S, Rossiter G, Villegas MT.Sphincter of Oddi manometry in healthy volunteers Dig Dis Sci 1990;35:38-46.
38. Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP.The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction N Engl J Med 1989;320:82-7.
39. Toouli J, Roberts-Thomson IC, Kellow J, Dowsett J, Saccone GT, Evans P, et al.Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction Gut 2000;46:98-102.
40. Sherman S, Lehman GA.Sphincter of Oddi dysfunction: diagnosis and treatment JOP 2001;2:382-400.
41. Eversman D, Fogel EL, Rusche M, Sherman S, Lehman GA.Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction Gastrointest Endosc 1999;50:637-41.
42. Rolny P, Anderberg B, Ihse I, Lindstrom E, Olaison G, Arvill A.Pancreatitis after sphincter of Oddi manometry Gut 1990;31:821-4.
43. Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter Gastrointestinal Endosc 1990;36:462-6.
44. Maldonado ME, Brady PG, Mamel JJ, Robinson B.Incidence of pancreatitits in patients undergoing sphincter of Oddi manometry (SOM) Am J Gastroenterol 1999;94:387-90.
45. Wehrmann T, Schmitt T, Schonfeld A, Caspary WF, Seifert H.Endoscopic sphincter of Oddi manometry with a portable electronic microtransducer system: comparison with the perfusion manometry method and routine clinical application Endoscopy 2000;32:444-51.
46. Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatic than biliary sphincterotomy alone Endoscopy 2002;34:280.